These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29033215)

  • 21. Importance of controlling drug-resistant Pseudomonas aeruginosa infection: experience from lung transplantation in a cystic fibrosis case.
    Yamamoto Y; Izumikawa K; Hara A; Fujita H; Amenomori M; Sakamoto N; Seki M; Kakeya H; Yanagihara K; Takasaki K; Miyazaki T; Tsuchiya T; Yamasaki N; Tagawa T; Nagayasu T; Kohno S
    Intern Med; 2010; 49(21):2353-8. PubMed ID: 21048374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Micronaut Merlin automated broth microtiter system with the standard agar dilution method for antimicrobial susceptibility testing of mucoid and nonmucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Balke B; Hoy L; Weissbrodt H; Häussler S
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):765-71. PubMed ID: 15605183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
    Lahiri T
    Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonal infection in cystic fibrosis: the battle continues.
    Elkin S; Geddes D
    Expert Rev Anti Infect Ther; 2003 Dec; 1(4):609-18. PubMed ID: 15482158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
    Stefani S; Campana S; Cariani L; Carnovale V; Colombo C; Lleo MM; Iula VD; Minicucci L; Morelli P; Pizzamiglio G; Taccetti G
    Int J Med Microbiol; 2017 Sep; 307(6):353-362. PubMed ID: 28754426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.
    Vickery SB; McClain D; Wargo KA
    Pharmacotherapy; 2016 Oct; 36(10):e154-e159. PubMed ID: 27522066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.
    Prickett MH; Hauser AR; McColley SA; Cullina J; Potter E; Powers C; Jain M
    Thorax; 2017 Jan; 72(1):40-47. PubMed ID: 27325751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments.
    Brugha RE; Davies JC
    Br J Hosp Med (Lond); 2011 Nov; 72(11):614-9. PubMed ID: 22083001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scorpionfish BPI is highly active against multiple drug-resistant
    Holzinger JM; Toelge M; Werner M; Ederer KU; Siegmund HI; Peterhoff D; Blaas SH; Gisch N; Brochhausen C; Gessner A; Bülow S
    Elife; 2023 Jul; 12():. PubMed ID: 37461324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Treggiari MM; Rosenfeld M; Retsch-Bogart G; Gibson R; Ramsey B
    Pediatr Pulmonol; 2007 Sep; 42(9):751-6. PubMed ID: 17647287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Hansen C; Skov M
    Ther Adv Respir Dis; 2015 Feb; 9(1):16-21. PubMed ID: 25471692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Parkins MD; Elborn JS
    Expert Rev Respir Med; 2011 Oct; 5(5):609-22. PubMed ID: 21955231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients.
    Denton M; Todd NJ; Littlewood JM
    Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):402-5. PubMed ID: 8793400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
    Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
    Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does monotherapy of pulmonary infections in cystic fibrosis lead to early development of resistant strains of Pseudomonas aeruginosa?
    Watkins J; Francis J; Kuzemko JA
    Scand J Gastroenterol Suppl; 1988; 143():81-5. PubMed ID: 3133756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis.
    Jackson L; Waters V
    J Cyst Fibros; 2021 Jan; 20(1):8-16. PubMed ID: 33172756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections.
    Driscoll JA; Brody SL; Kollef MH
    Drugs; 2007; 67(3):351-68. PubMed ID: 17335295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.